Explore Cancer Biology at the Protein Level:
Over 300 Pan-Cancer Markers Validated on Human Cancers
Cancer involves complex molecular mechanisms beyond genetic mutations. While genomic and transcriptomic data are essential, protein-level expression provides direct insight into cellular function and tumor behavior. This collection of Pan-Cancer markers includes over 300 primary antibodies, selected based on TCGA Pan-Cancer Atlas data and validated on human cancer tissues and cell lines. These markers support the identification of shared oncogenic pathways and are applicable across a broad range of tumor types. All antibodies are IHC-validated and supported by additional data from the Human Protein Atlas database, offering robust tools for proteomic phenotyping and integrative cross-cancer research.